How did Zimmerbaomit Holdings' revenue and expenses trend in Q4 2024?
4/14/2025 12:39am
Zimmer Biomet Holdings' revenue and expenses in Q4 2024 showed a business-focused trend, with a strong revenue stream primarily driven by the Knees and Hips segments, and a corresponding increase in operating and administrative expenses:
1. **Revenue Trend**: Zimmer Biomet's revenue for Q4 2024 was $3.17 billion, which can be segmented as follows:
- Knees: $3.17 billion
- Hips: $2.33 billion
- Other: $640.3 million (primarily Surgical, Sports Medicine, Biologics, Foot and Ankle, Extremities, and Trauma Product Category)
2. **Expense Trend**: The company's operating expenses, including Selling, General, and Administrative (SG&A) costs, were $904.5 million. These expenses are essential for supporting the business operations and maintaining market position.
- SG&A Expenses: $904.5 million
- Net Income: $240 million
The data indicates a robust revenue generation capacity, particularly in the Knees and Hips segments, which is a positive indicator for the company's financial performance. However, the high SG&A expenses highlight the need for effective cost management to maintain profitability.
|code|Ticker|Name|Date|Business Composition|Revenue By Business|market_code|
|---|---|---|---|---|---|---|
|ZBH|ZBH.N|Zimmer Biomet|20240101-2024|Other|6.403E8|169|
|ZBH|ZBH.N|Zimmer Biomet|20240101-2024|Other|4.656E8|169|
|ZBH|ZBH.N|Zimmer Biomet|20240101-2024|Other|3.222E8|169|
|ZBH|ZBH.N|Zimmer Biomet|20240101-2024|Other|1.573E8|169|
|ZBH|ZBH.N|Zimmer Biomet|20240101-2024|Other|1.573E8|169|
|ZBH|ZBH.N|Zimmer Biomet|20240101-2024|Knees|7.881E8|169|
|ZBH|ZBH.N|Zimmer Biomet|20240101-2024|Surgical,Sports Medicine,Biologics,Foot and Ankle,Extremities and Trauma Product Category|4.526E8|169|
|ZBH|ZBH.N|Zimmer Biomet|20240101-2024|Hips|4.912E8|169|
|code|Ticker|Name|Date|Net Income YoY|Net Income|market_code|
|---|---|---|---|---|---|---|
|ZBH|ZBH.N|Zimmer Biomet|2024 Q1|-25.773195876288657|1.728E8|169|
|ZBH|ZBH.N|Zimmer Biomet|2024 Q2|15.817055740828966|2.431E8|169|
|ZBH|ZBH.N|Zimmer Biomet|2024 Q3|53.07125307125307|2.492E8|169|
|ZBH|ZBH.N|Zimmer Biomet|2024 Q4|-42.802669208770254|2.4E8|169|
|code|Ticker|Name|Date|Selling, General, and Administrative Expenses|Selling, General, and Administrative Expenses YoY|market_code|
|---|---|---|---|---|---|---|
|ZBH|ZBH.N|Zimmer Biomet|20240331|8.783E8|3.4145767102319557|169|
|ZBH|ZBH.N|Zimmer Biomet|20240630|8.811E8|1.9791666666666665|169|
|ZBH|ZBH.N|Zimmer Biomet|20240930|8.579E8|4.6347115501890475|169|
|ZBH|ZBH.N|Zimmer Biomet|20241231|9.045E8|4.30119926199262|169|